基于PROTAC的蛋白质降解:黑色素瘤治疗的机会之窗
Giulia Gentile1, Simona D'Aguanno2, Marta Di Martile1
1Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Journal of biomedical science
|February 27, 2026
概括
蛋白质溶解向基因组 (PROTACs) 是一种新型疗法,可诱导向蛋白质降解. 本综述侧重于皮肤黑色素瘤的PROTACs,总结了临床前数据,以推进个性化癌症治疗.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 药物发现 药物发现 药物发现
背景情况:
- 向蛋白质降解是一种快速发展的治疗方式.
- 蛋白质溶解T向基因组 (PROTACs) 是异构功能分子,它们诱导目标蛋白和E3结合酶之间的接近,导致蛋白质无处不在和降解.
- 通过向以前无法药物治疗的蛋白质,PROTACs显示出对治疗包括癌症在内的各种疾病的希望.
研究的目的:
- 综合审查关于PROTACs在皮肤黑色素瘤中的使用的临床前发现.
- 巩固现有研究,并突出突出在黑色素瘤的PROTACs的不断发展领域的努力.
- 为科学家和临床医生提供见解,以推进个性化癌症治疗.
主要方法:
- 对皮肤黑色素瘤中PROTACs的临床前研究的文献综述.
- 讨论当前的研究趋势和挑战.
- 综合数据以确定未来研究和临床翻译的机会.
主要成果:
- 在各种癌症的临床前模型中,PROTACs已经证明了其有效性.
- 虽然PROTAC正在瘤学临床试验中取得进展,但对皮肤黑色素瘤的具体数据有限.
- 这次审查整合了现有的临床前数据,确定了潜在的应用和研究缺口.
结论:
- PROTAC技术为皮肤黑色素瘤提供了一个有前途的治疗策略.
- 需要进一步的临床前研究和临床开发,才能充分发挥PROTACs在治疗这种侵袭性皮肤癌的潜力.
- 这一综述为基于PROTAC的黑色素瘤治疗的未来研究和开发提供了基础.
相关概念视频
The Proteasome
10.4K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.4K
The Proteasome
1.9K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.9K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Regulated Protein Degradation
9.1K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.1K
Regulated Protein Degradation
3.3K
3.3K
Proteins: From Genes to Degradation
14.7K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
Transcription is the synthesis of RNA...
14.7K


